October 31, 2014
Paul Watkins, MD, is the recipient of the the 2015 Rawls-Palmer Progress in Medicine Award from the American Institute of Clinical Pharmacology and Therapeutics for multiple contributions to the field of clinical pharmacology.
Watkins is a professor in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy and a professor of toxicology at the UNC Gillings School of Public Health. He is director of the Hamner–UNC Institute for Drug Safety Sciences.
Established in 1978, the Rawls-Palmer award is given to those who contribute meaningful research that improves patient care. Watkins has been invited to give more than 180 talks worldwide regarding his research on enzymes that metabolize medication, grapefruit-drug interactions, and drug-induced liver injury. With more than 170 original manuscripts and thirty book chapters published, Watkins’ research has been cited more than 14,000 times.
Watkins is one of seven people to win a 2015 ASCPT award and will receive official recognition during the 2015 annual ASCPT meeting in March.
Watkins received his medical degree from Cornell Medical College in 1979 and has been teaching at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill since 1999.
Watkins will be given his award during the ASCPT annual meeting in New Orleans, La., where he will receive $1,000 and give a lecture on drug-induced liver injury to several thousand people. He has served as chair of the steering committee for the U.S. Drug-Induced Liver Injury network since 2004 and was a founding director of the Hamner-UNC Institute for Drug Safety Sciences.
By Aren Besson
Latest News
RASP poster presentations capture student research
Delesha Carpenter promoted to full professor
